Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma
about
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy.Anaplastic lymphoma kinase is required for neurogenesis in the developing central nervous system of zebrafish.Intrinsic susceptibility MRI identifies tumors with ALKF1174L mutation in genetically-engineered murine models of high-risk neuroblastomaThe Niemann-Pick C1 Inhibitor NP3.47 Enhances Gene Silencing Potency of Lipid Nanoparticles Containing siRNA.Anaplastic lymphoma kinase protein expression predicts micrometastases and prognosis for patients with hepatocellular carcinomaNew therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation AssayALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma.Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma.More than the genes, the tumor microenvironment in neuroblastoma.Antibody-coupled siRNA as an efficient method for in vivo mRNA knockdown.Peptides derived from the dependence receptor ALK are proapoptotic for ALK-positive tumors.Lipid nanoparticle delivery systems for siRNA-based therapeutics.Advances in Lipid Nanoparticles for siRNA Delivery.Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignanciesA Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A.Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targeting.The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma.
P2860
Q34389202-0B11900E-AB05-4146-93BC-650B4AFAA65DQ34718402-BC391375-F2C4-4D7B-BE5D-722079B25127Q35131527-F03ACE33-E987-4DC2-8894-1ED5E1DAC8C4Q36134911-A96B0B6F-F837-4755-8E12-3F37E4B4250CQ36502649-6A670E49-282B-463A-B4F9-F7F2408052FEQ36557133-8E3AF1A2-960A-4B1F-9734-7A01DEFB1C8EQ37338152-18E30AF1-BF62-4E90-9E81-F31991DDF75BQ37405597-0D4B1435-56AA-479E-AFD5-FC009C0C4D6EQ38128317-1CE79B9B-1F93-45F3-87F1-DA4F27BEA421Q38644731-3CFB7CE0-CD65-4169-8BCA-8104082E3BAFQ38814625-2F006810-7BB2-46C8-875B-07618DC184F2Q38878195-C976F403-4F54-4A21-A880-03DA92513506Q39027758-F599BDAD-2EE1-41D5-A390-4897FBE23A0BQ41786279-DF8D0F8E-470E-482C-88A2-A74FC299C1ECQ42737898-431539CD-1F0F-4D66-8240-912A80EDF402Q45864008-ACDFAA5D-A141-4BC4-91DF-4BF8F4F63190Q50476547-1395D18F-6DF4-4237-AAAF-C42AC353D4C2Q55070857-E656B813-2C78-4C97-A8DF-CFD539164127
P2860
Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Selective therapeutic targetin ...... angiogenesis in neuroblastoma
@ast
Selective therapeutic targetin ...... angiogenesis in neuroblastoma
@en
type
label
Selective therapeutic targetin ...... angiogenesis in neuroblastoma
@ast
Selective therapeutic targetin ...... angiogenesis in neuroblastoma
@en
prefLabel
Selective therapeutic targetin ...... angiogenesis in neuroblastoma
@ast
Selective therapeutic targetin ...... angiogenesis in neuroblastoma
@en
P2093
P2860
P50
P356
P1433
P1476
Selective therapeutic targetin ...... angiogenesis in neuroblastoma
@en
P2093
Chiara Brignole
Cinzia Martinengo
Laura Emionite
Michele Cilli
Monica Loi
Roberta Carosio
Theresa M Allen
P2860
P304
P356
10.1038/MT.2011.142
P50
P577
2011-08-09T00:00:00Z